5469-70-5 | Pyridazin-3-amine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$10.00	$7.00
5g	98%	in stock	$15.00	$11.00
10g	95%	in stock	$17.00	$12.00
15g	95%	in stock	$25.00	$18.00
25g	95%	in stock	$41.00	$29.00
100g	98%	in stock	$149.00	$104.00

Description

• Catalog Number: AB44430
• Chemical Name: Pyridazin-3-amine
• CAS Number: 5469-70-5
• Molecular Formula: C4H5N3
• Molecular Weight: 95.1026
• MDL Number: MFCD01529869
• SMILES: Nc1cccnn1
• NSC Number: 25228

Computed Properties

• Complexity: 54.9
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• XLogP3: -1.2

Literature

• Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.

  Journal of medicinal chemistry 20160526

• Competitive antagonism of insect GABA receptors by iminopyridazine derivatives of GABA.

  Bioorganic & medicinal chemistry 20121001

• In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.

  PloS one 20100101

• Polyfunctional nitriles in organic syntheses: a novel route to aminopyrroles, pyridazines and pyrazolo[3,4-c]pyridazines.

  Molecules (Basel, Switzerland) 20090216

• A novel and convenient protocol for synthesis of pyridazines.

  Organic letters 20090115

• R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.

  Antiviral research 20080601

• Privileged structures: a useful concept for the rational design of new lead drug candidates.

  Mini reviews in medicinal chemistry 20071101

• Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries.

  Molecular diversity 20060801

• De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disorders.

  Current Alzheimer research 20060701

• Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation.

  Journal of molecular neuroscience : MN 20040101

• Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo.

  Neurobiology of aging 20040101

• An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury.

  Bioorganic & medicinal chemistry letters 20031020

• Discovery of new chemical classes of synthetic ligands that suppress neuroinflammatory responses.

  Journal of molecular neuroscience : MN 20020101

• Serotonin receptor and transporter ligands - current status.

  Current medicinal chemistry 20010701

• Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors.

  Journal of computer-aided molecular design 20010501